All In MedTech

Device Trial Radar · NCT04660396

Monitoring Outpatient Blood VolumE in Heart Failure

Last checked: Nov 20, 2026Latest source record: Sep 29, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

15

Actual

Start

Sep 16, 2021

Primary completion

Jul 15, 2022

Study completion Jul 30, 2022

Sponsor

Lead sponsor
Daxor CorporationNot on our public-company list
Sponsor type
Industry
Collaborators
Geisinger Clinic
First posted
Dec 9, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In patients discharged following heart failure treatment, the consistency of blood volume status and components over time is unknown. The primary objective is to describe the rate of change, if any, of the plasma volume and red blood cell volume following hospitalization and discharge of patients with heart failure.

Conditions

  • Heart Failure

Interventions

  • BVA-100Device

    The BVA-100 is a software package designed to calculate human blood volume using the method of tracer dilution. It uses tagged serum albumin (a commonly used tag is 131I, resulting in "131I -HSA"). Data inputs to the software come from the measured characteristics of subject blood samples (hematocrit and tracer concentration) and tracer calibration standards. The package also calculates the subject expected (or ideal) blood volume from physical parameters. Hyper- or hypovolemia, associated red blood cell volumes, and transudation rate are reported, with statistics showing the quality of the results. The subject blood samples and calibration standards are measured in a gamma counter, whose output is automatically, or manually, input to this calculation program.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quantify volume shifts in post discharge heart failure patientsTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Geisinger

    Danville, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.